BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 223 filers reported holding BIONTECH SE in Q1 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $761,132 | -2.5% | 7,006 | -3.2% | 0.00% | 0.0% |
Q2 2023 | $780,766 | -44.1% | 7,234 | -35.5% | 0.00% | -57.1% |
Q1 2023 | $1,397,551 | -31.6% | 11,219 | -17.5% | 0.01% | -36.4% |
Q4 2022 | $2,043,443 | -2.7% | 13,603 | -12.6% | 0.01% | -8.3% |
Q3 2022 | $2,100,000 | -35.8% | 15,568 | -29.1% | 0.01% | -36.8% |
Q2 2022 | $3,273,000 | -43.6% | 21,954 | -35.5% | 0.02% | -34.5% |
Q1 2022 | $5,807,000 | -20.2% | 34,046 | +20.2% | 0.03% | -17.1% |
Q4 2021 | $7,278,000 | +116.5% | 28,332 | +130.1% | 0.04% | +94.4% |
Q3 2021 | $3,361,000 | +5.6% | 12,312 | -13.0% | 0.02% | 0.0% |
Q2 2021 | $3,184,000 | +20.9% | 14,155 | -41.3% | 0.02% | +12.5% |
Q1 2021 | $2,633,000 | +35.2% | 24,118 | +0.9% | 0.02% | +33.3% |
Q4 2020 | $1,948,000 | +25.7% | 23,896 | +6.7% | 0.01% | +9.1% |
Q3 2020 | $1,550,000 | +3.6% | 22,395 | -0.1% | 0.01% | -15.4% |
Q2 2020 | $1,496,000 | – | 22,415 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
Robbins Farley | 13,220 | $2,255,000 | 1.70% |
APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |